Deca-durabolin side effects by duration, gender and age - a phase IV clinical study of FDA data
Side effects are reported by people who take Deca-durabolin. Common side effects include ankle fracture among females, and blood creatine phosphokinase increased among males.
The phase IV clinical study is created by eHealthMe based on 151 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
151 people who take Deca-Durabolin and have side effects are studied.
What is Deca-Durabolin?
Deca-durabolin has active ingredients of nandrolone decanoate. It is used in muscle building therapy. Currently, eHealthMe is studying from 173 Deca-durabolin users.
Number of Deca-durabolin reports submitted per year:
Deca-durabolin side effects by time on the drug *:
Deca-durabolin side effects by gender *:
Deca-durabolin side effects by age *:
* Approximation only. Some reports may have incomplete information.
Do you take Deca-durabolin?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How the study uses the data?
The study is based on nandrolone decanoate (the active ingredients of Deca-durabolin) and Deca-durabolin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Alternative drugs to, pros and cons of Deca-durabolin:
- Deca-durabolin (173 reports)
All Deca-durabolin side effects from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Lomotil and Weakness - now
- Lomotil and Nausea And Vomiting - 22 seconds ago
- Lopurin and Indocin drug interaction - 24 seconds ago
- Orencia and Drug Specific Antibody Present - 46 seconds ago
- Daunorubicin Hydrochloride and Methotrexate drug interaction - a minute ago
- Permax and Symmetrel drug interaction - a minute ago
- Daunorubicin Hydrochloride and Vincristine Sulfate drug interaction - a minute ago
- Pulmicort Respules and Mucinex drug interaction - a minute ago
- Nortriptyline Hydrochloride and Climara drug interaction - a minute ago
- Tapentadol and Drug Ineffective - 2 minutes ago